阻抗控制子宫内膜去除术（NovaSure）治疗月经过多的临床.docVIP

阻抗控制子宫内膜去除术（NovaSure）治疗月经过多的临床观察 NovaSure）治疗月经过多的有效性及安全性。方法：回顾性分析2011年1月～2012年7月在我院行阻抗控制子宫内膜去除术且术后随访3个月的129例月经过多患者的临床资料，其中包括有严重并发症的患者22例。结果：129例患者均顺利完成手术，术中出血量少，术中术后无严重手术相关并发症发生，术后 3个月后随访显示闭经者103例，仍有少量阴道流血者25例，月经无明显改善者1例，闭经率为79.84%，治疗有效率为99.22%，99.22%的患者对治疗效果满意。结论：阻抗控制子宫内膜去除术是一种治疗月经过多安全有效的治疗方法，对于有严重合并症的月经过多患者可优先考虑此手术。 关键词：月经过多；子宫内膜去除术；诺舒 NovaSure impedance controlled endometrial ablation for hypermenorrhea JIANG Jian-fa, XIAO Song-shu, XUE Min Department of Gynecology and Obstetrics, Third Xiangya Hospital, Central South University, Changsha 410013, China Abstract: Objective To investigate the efficacy and safety of NovaSure impedance controlled endometrial ablation treatment of women with hypermenorrhea．Methods From January 2011 to July 2012, 129 women with hypermenorrhea were treated with NovaSure impedance controlled endometrial ablation in our hospital, including 22 patients with severe complication, all of them were successfully followed-up for three months. Their clinical data were retrospectively analyzed. Results The procedure was completed successfully in all the patients. The blood loss was little and there were no severe surgical complications. 103 patients were amenorrhea, 25 patients were low menstrual volume and only one patient remained hypermenorrhea after surgery. The rate of amenorrhea was 79.84%; the rate of efficacy was 99.22%. 99.22% of the patients were satisfied with this treatment. Conclusion NovaSure impedance controlled endometrial ablation was safe and effective, especially for the patients with severe complication． Key Words: hypermenorrhea; endometrial ablation; NovaSure 女性正常月经的临床表现为经期2～7天，周期21～35天，经量为30～50 ml。通常将经量超过80 ml或经期超过7天称为月经过多[1]。月经过多是妇科常见疾病，功能失调性子宫出血是导致月经过多的常见良性疾病，慢性肾功能不全、血小板减少、凝血功能障碍等严重内科疾病均可导致月经过多，严重影响患者的生活质量。阻抗控制子宫内膜去除术即NovaSure阻抗控制子宫内膜切除系统，简称诺舒手术，是治疗月经过多的有效手术方式。此治疗系统自2001年上市，到目前为止，全球约有100万女性接受了阻抗控制子宫内膜去除术治疗[2]，且取得了满意的疗效。然而，该手术在我国的开展较晚，国内关于该手术治疗效果的报道很少。我院自2011年开始引进阻抗控制子宫内膜去除术治疗月经过多，取得了满意的效果，现报道如下： 1.资料与方法 1.1 一般资料 2011年1月～20